FDA Inspection 1166854 — Amit (Nmi)Mahipal MD
The FDA completed an inspection of Amit (Nmi)Mahipal MD on Mar 22, 2022 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 22, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rochester, MN (United States)
Additional details
Clinical Investigator (CI)